Evidence map›Paper›PMID 32448864›Full record

ArticleThe American journal of case reports2020

Stenotrophomonas maltophilia: An Emerging Pathogen of the Respiratory Tract.

Tejaswi Kanderi, Isha Shrimanker, Qurat Mansoora, Kajol Shah, Anna Yumen, Saketram Komanduri

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Navigating the Challenges ofClinical case reports · 2026
    Article
  2. Frontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. A guide toFrontiers in cellular and infection microbiology · 2023
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Tejaswi KanderiDepartment of Internal Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA.
Isha ShrimankerDepartment of Internal Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA.
Qurat MansooraDepartment of Internal Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA.
Kajol ShahDepartment of Internal Medicine, Drexel University College of Medicine, Philadelphia, PA, USA.
Anna YumenDepartment of Internal Medicine, Penn State College of Medicine, Hershey, PA, USA.
Saketram KomanduriDepartment of Internal Medicine, University of Pittsburgh Medical Center (UPMC) Pinnacle, Harrisburg, PA, USA.
University of Pittsburgh Medical Center · USUPMC Central Pa · USDrexel University · USPenn State Milton S. Hershey Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Stenotrophomonas maltophilia has the propensity to cause a plethora of opportunistic infections in humans owing to biofilm formation and antibiotic resistance. It is often seen as a co-organism along with Pseudomonas aeruginosa. CASE REPORT A 70-year-old woman with several co-morbidities presented reporting hypoglycemia and dyspnea. An imaging study of the chest was suggestive of deterioration of pneumonia, with increased opacities. Initial respiratory cultures were negative, while subsequent repeat cultures revealed the growth of Stenotrophomonas maltophilia susceptible to trimethoprim plus sulfamethoxazole and levofloxacin. The patient had a poor prognosis and eventually died despite appropriate measures. CONCLUSIONS A decline in the clinical status of a patient such as ours makes it hard to quickly diagnose this organism correctly. Physicians should thus be cautious of Stenotrophomonas maltophilia-induced infection and more emphasis should be placed on appropriate treatment due to the emerging risk of antibiotic resistance.

Indexed as

AgedAnti-Bacterial AgentsFatal OutcomeFemaleGram-Negative Bacterial InfectionsHeart ArrestHumansLevofloxacinOpportunistic InfectionsPneumoniaSepsisStenotrophomonas maltophiliaTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsLevofloxacinTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID32448864
PMCPMC7274500
OpenAlexW3026933313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.